spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 30 September 2008
doi: 10.1242/jcs.035691


Journal of Cell Science 121, 3335-3346 (2008)
Published by The Company of Biologists 2008
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow All Versions of this Article:
jcs.035691v1
121/20/3335    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Mitra, S.
Right arrow Articles by Plattner, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitra, S.
Right arrow Articles by Plattner, R.

Research Article

SHP-2 is a novel target of Abl kinases during cell proliferation

Sayan Mitra1, Carol Beach2, Gen-Sheng Feng3 and Rina Plattner1,*

1 Department of Molecular and Biomedical Pharmacology, University of Kentucky, Lexington, KY 40536, USA
2 Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA
3 Burnham Institute for Medical Research, La Jolla, CA 92037, USA

* Author for correspondence (e-mail: rplat2{at}uky.edu)

Accepted 14 July 2008

Previously, we showed that Abl family tyrosine kinases are activated by growth factors, and Abl is required for transition from G1 to S phase during PDGF-mediated proliferation. Here, we show that the SHP-2 tyrosine phosphatase, which acts to promote proliferation in response to cytokines and growth factors, is a novel substrate of endogenous Abl kinases during growth factor-mediated cellular proliferation. Using a pharmacological inhibitor and RNAi, we show that endogenous Abl kinases phosphorylate SHP-2 on Y580, and induce sustained activation of ERK kinases in response to growth factor stimulation in fibroblasts. Consistent with these data, SHP-2 is required for Abl-dependent PDGF-mediated proliferation since expression of an activated form of SHP-2 rescues the ability of Abl-Arg null fibroblasts to transit from G1 to S phase, whereas inhibition of SHP-2 signaling reduces the ability of Abl kinases to rescue the proliferation defect. Abl kinases also indirectly mediate phosphorylation of SHP-2 on Y63 and Y279, which are frequent sites of germline mutation in two cancer susceptibility syndromes. Significantly, we demonstrate that phosphorylation of SHP-2 on Y279 downregulates growth factor-induced sustained ERK activation and proliferation, supporting a role for Abl kinases not only in potentiating growth factor-mediated SHP-2 signaling, but also in negative-feedback regulation.

Key words: Abl, Arg, SHP-2, Proliferation, ERK


Related articles in JCS:

Abl and SHP-2: proliferative partners

JCS 2008 121: 2002. [Full Text]  






© The Company of Biologists Ltd 2008